Results
|
5701.
|
|
|
5702.
|
|
|
5703.
|
|
|
5704.
|
|
|
5705.
|
|
|
5706.
|
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab. [electronic resource] by
- Freeman, C L
- Dixon, M
- Houghton, R
- Kreuzer, K-A
- Fingerle-Rowson, G
- Herling, M
- Humphrey, K
- Böttcher, S
- de Costa, C S
- Iglesias, V
- Stilgenbauer, S
- Gribben, J
- Hallek, M
- Goede, V
Producer: 20180209
In:
Leukemia vol. 30
Availability: No items available.
|
|
5707.
|
|
|
5708.
|
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients. [electronic resource] by
- Alping, Peter
- Frisell, Thomas
- Novakova, Lenka
- Islam-Jakobsson, Protik
- Salzer, Jonatan
- Björck, Anna
- Axelsson, Markus
- Malmeström, Clas
- Fink, Katharina
- Lycke, Jan
- Svenningsson, Anders
- Piehl, Fredrik
Producer: 20170607
In:
Annals of neurology vol. 79
Availability: No items available.
|
|
5709.
|
|
|
5710.
|
|
|
5711.
|
|
|
5712.
|
|
|
5713.
|
|
|
5714.
|
|
|
5715.
|
|
|
5716.
|
|
|
5717.
|
|
|
5718.
|
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience. [electronic resource] by
- Herishanu, Yair
- Tadmor, Tamar
- Braester, Andrei
- Bairey, Osnat
- Aviv, Ariel
- Rahimi-Levene, Naomi
- Fineman, Riva
- Levi, Itai
- Yuklea, Mona
- Ruchlemer, Rosa
- Shvidel, Lev
- Polliack, Aaron
Producer: 20190507
In:
Hematological oncology vol. 37
Availability: No items available.
|
|
5719.
|
|
|
5720.
|
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature. [electronic resource] by
- Traineau, Hélène
- Aggarwal, Rohit
- Monfort, Jean-Benoît
- Senet, Patricia
- Oddis, Chester V
- Chizzolini, Carlo
- Barbaud, Annick
- Francès, Camille
- Arnaud, Laurent
- Chasset, François
Producer: 20200813
In:
Journal of the American Academy of Dermatology vol. 82
Availability: No items available.
|